today

2026 Kia Sportage Named 2025 TOP SAFETY PICK+ in 2025 IIHS Crash Test Ratings

2026 Kia SPORTAGE earns highest-tier 2025 TOP SAFETY PICK+ (TSP+) rating from the U.S. Insurance Institute for Highway Safety (IIHS)Result…

2 months ago

13th Edition of Tiger Cup 2025, Supported by Cycle Pure Agarbathi, Kicks Off with Debut of Girls' League

Cycle Pure Agarbathi inaugurates the 13th edition of the Tiger Cup 2025, a cricket tournament for the under 12, under…

2 months ago

Edesa Biotech Announces Upcoming Conference Schedule

TORONTO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics…

2 months ago

Lucas GC Limited Announces 1H 2025 Financial Results: Revenue at US$54.01 million with Increases in Gross Margin

October 31, 2025 17:00 ET  | Source: Lucas GC Limited NEW YORK, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Lucas GC…

2 months ago

Hyundai Motor Group Announces NVIDIA Blackwell AI Factory to Power Fleet of AIDriven Mobility Solutions

Hyundai Motor Group and NVIDIA will collaborate with the Korean government to develop Korea’s physical AI industry, including the establishment…

2 months ago

Kia Announces 2025 Third Quarter Business Results

Kia posts Q3 revenue of KRW 28.69 trillion, up 8.2% Y/yQ3 global sales of 785,137 units, up 2.8% Y/yQ3 operating…

2 months ago

The global campaign ‘7 Wonders of Future Cities’ from New7Wonders starts on World Cities Day

DUBAI, UAE, Oct. 30, 2025 /PRNewswire/ -- New7Wonders, the world's official authority for public voting to choose Wonders, today formally…

2 months ago

Big Daddy Casino Group Clarifies ED Inquiries, Refutes Seizure Claims

PANAJI, Goa, Oct. 31, 2025 /PRNewswire/ -- M/s. Golden Globe Hotels Pvt. Ltd., M/s. Worldwide Resorts and Entertainment Pvt. Ltd., Big…

2 months ago

CORRECTION Micron Announces Participation in Investor Event

BOISE, Idaho, Oct. 30, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, October 30th…

2 months ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

2 months ago